Gifford Fong Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Gifford Fong Associates's LLY Position: Q1 2024 in Review
Gifford Fong Associates sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 16,100 shares — an estimated $9.38M sold.
Gifford Fong Associates first reported a position in LLY in Q1 2018 and held it in 24 quarters. The position peaked at $9.38M in Q4 2023. 3,461 funds tracked by Wall St. Rank hold LLY as of Q1 2024.
- Gifford Fong Associates reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
- Gifford Fong Associates sold 16,100 Eli Lilly shares in Q1 2024, an estimated $9.38M.
- Gifford Fong Associates first reported a position in Eli Lilly in Q1 2018 and held it in 24 quarters.
- Gifford Fong Associates's Eli Lilly position peaked at $9.38M in Q4 2023.
- 3,461 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.
Based on Gifford Fong Associates's 13F filing for Q1 2024, filed 10 May 2024.